Evidence map›Paper›PMID 33514598›Full record

Observational studyGut2021

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways.

María Arnoriaga-Rodríguez, Jordi Mayneris-Perxachs, Oren Contreras-Rodríguez, Aurelijus Burokas, Juan-Antonio Ortega-Sanchez, Gerard Blasco, Claudia Coll, Carles Biarnés, Anna Castells-Nobau, Josep Puig and 19 more

2 registry-linked trialsOpen access · hybridAbstract readObservational Study
In one paragraph

Observational study in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05345106 active not recruitingnot on this mapstarted 2022, after this paper: background citation

Inter-relationships Among Iron Stores, the Gut Metagenome, Glucose Levels, and Different Cognitive Domains: the Role of Circulating MicroRNAs (IRONmiRNA Study).

TypeobservationalSponsorInstitut d'Investigació Biomèdica de Girona Dr. Josep TruetaRan2022 to 2027Enrolled138ConditionsObesityArmsBariatric Surgery
NCT05646901 recruitingnot on this mapstarted 2022, after this paper: background citation

Involvement of the Gut Microbiota-brain Cross-talk in the Loss of Eating Control (GMBCrossTalkFood)

TypeobservationalSponsorInstitut d'Investigació Biomèdica de Girona Dr. Josep TruetaRan2022 to 2027Enrolled116ConditionsObesity
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Review
  3. Gut microbes · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Targeting one-carbon metabolism for cancer immunotherapy.Clinical and translational medicine · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 10 institutions in 3 countries.

María Arnoriaga-Rodríguez *Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain.ORCID 0000-0002-0394-1223
Jordi Mayneris-Perxachs *Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain jmayneris@idibgi.org rafael.maldonado@upf.edu jmfreal@idibgi.org.ORCID 0000-0003-3788-3815
Oren Contreras-RodríguezNutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IdibGi), Girona, Spain.ORCID 0000-0001-8922-8084
Aurelijus BurokasLaboratory of Neuropharmacology, Deparment of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-0364-3496
Juan-Antonio Ortega-SanchezLaboratory of Neuropharmacology, Deparment of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Gerard BlascoInstitute of Diagnostic Imaging (IDI)-Research Unit (IDIR), Parc Sanitari Pere Virgili, Barcelona, Spain.
Claudia CollNeuroimmunology and Multiple Sclerosis Unit, Deparment of Neurology, Dr. Josep Trueta University Hospital, Girona, Spain.
Carles BiarnésMedical Imaging, Girona Biomedical Research Institute (IdibGi), Girona, Spain.
Anna Castells-NobauDepartment of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain.
Josep PuigDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.
Josep Garre-OlmoDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.
Rafel RamosDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.ORCID 0000-0001-7970-5537
Salvador PedrazaDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.
Ramon BrugadaDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.ORCID 0000-0001-6607-3032
Joan C VilanovaDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.ORCID 0000-0003-2148-6751
Joaquín SerenaDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.
Jordi BarretinaGirona Biomedical Research Institute (IdibGi), Dr. Josep Trueta University Hospital, Girona, Spain.
Jordi GichDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.
Vicente Pérez-BrocalJoint Investigation Unit of FISABIO and I2Sysbio, University of València and CSIC, Valencia, Spain.
Andrés MoyaJoint Investigation Unit of FISABIO and I2Sysbio, University of València and CSIC, Valencia, Spain.ORCID 0000-0002-2867-1119
Xavier Fernández-RealInstitute of Mathematics, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Lluis Ramio-TorrentàDeparment of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.ORCID 0000-0002-6999-1004
Reinald PamplonaMetabolic Physiopathology Research Group, Experimental Medicine Department, Lleida University-Lleida Biochemical Research Institute (UdL-IRBLleida), Lleida, Spain.
Joaquim SolMetabolic Physiopathology Research Group, Experimental Medicine Department, Lleida University-Lleida Biochemical Research Institute (UdL-IRBLleida), Lleida, Spain.
Mariona JovéMetabolic Physiopathology Research Group, Experimental Medicine Department, Lleida University-Lleida Biochemical Research Institute (UdL-IRBLleida), Lleida, Spain.ORCID 0000-0001-5577-6162
Wifredo RicartDepartment of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain.
Manuel Portero-OtinMetabolic Physiopathology Research Group, Experimental Medicine Department, Lleida University-Lleida Biochemical Research Institute (UdL-IRBLleida), Lleida, Spain.
Rafael MaldonadoLaboratory of Neuropharmacology, Deparment of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain jmayneris@idibgi.org rafael.maldonado@upf.edu jmfreal@idibgi.org.
Jose Manuel Fernández-RealDepartment of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain jmayneris@idibgi.org rafael.maldonado@upf.edu jmfreal@idibgi.org.ORCID 0000-0002-7442-9323
Universitat de Girona · ESInstitut d'Investigació Biomèdica de Girona · ESInstituto de Investigación Biomédica de Lleida · ESUniversitat Pompeu Fabra · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ESUniversitat de València · ESBellvitge University Hospital · ESÉcole Polytechnique Fédérale de Lausanne · CHHospital Universitari de Girona Doctor Josep Trueta · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInhibitory control (IC) is critical to keep long-term goals in everyday life. Bidirectional relationships between IC deficits and obesity are behind unhealthy eating and physical exercise habits.

methodsWe studied gut microbiome composition and functionality, and plasma and faecal metabolomics in association with cognitive tests evaluating inhibitory control (Stroop test) and brain structure in a discovery (n=156), both cross-sectionally and longitudinally, and in an independent replication cohort (n=970). Faecal microbiota transplantation (FMT) in mice evaluated the impact on reversal learning and medial prefrontal cortex (mPFC) transcriptomics.

resultsAn interplay among IC, brain structure (in humans) and mPFC transcriptomics (in mice), plasma/faecal metabolomics and the gut metagenome was found. Obesity-dependent alterations in one-carbon metabolism, tryptophan and histidine pathways were associated with IC in the two independent cohorts. Bacterial functions linked to one-carbon metabolism (

conclusionThese results highlight the importance of targeting obesity-related impulsive behaviour through the induction of gut microbiota shifts.

Indexed as

Fecal Microbiota TransplantationInhibition, PsychologicalAdultAgedAmino Acids, AromaticAnimalsCarbonCross-Sectional StudiesFatty LiverFemaleGastrointestinal MicrobiomeHumansMaleMiceMiddle AgedObesityAmino Acids, AromaticCarbonintestinal microbiologyobesity

Identifiers

PMID33514598
PMCPMC8588299
OpenAlexW3123783856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.